Letter to the Editor  by Kligman, Albert M
LETTER TO THE EDITOR 
Dear Doctor Stoughton: 
Dr. Mi tchell may innocently be misleading 
the misled . It is t rue enough t hat in vitro models 
of phototox icity may yield results which do not 
correspond t o human experien ce. However, the 
usual discrepancy is in t he category of a fal se 
negative result. For example, Freeman in his 
Hep-2 tissue culture syst em (Arch. Derm. 
102:521, 1970) was unable to identify chlor-
promazine and sulfonamide as phototoxic drugs. 
Using hemolysis of red cells as an indicator 
Kahn and Fleischaker (J. I. D. 56:85, 1971) 
obtained negative results with such potent 
photosensitizers as Declomycin and 8-methoxy-
psoralen . Mitchell now confronts t he opposite 
possibility-the false posit ive result. Much as 
we need to be reminded of divergences between 
models and clinical realiti es, Mitchell's case is 
unproved. Daniel's C. albicans lysis system is 
quite sensiti1·e and does not require high energy 
sources of long ultra-violet radiation . This is not 
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t rue when skin is used. Moreover, one has to 
insure that the substance has diffused into the 
skin after topical application. That t etramethyl-
thiuram monosulfide is not a photosensitizer 
would have been more convincingly documented 
had it been inj ect ed intradermally or applied to 
stripped skin as WiLlis and myself have advised. 
As regards the lack of clinical evidence of 
phototoxicity in subjects taking the drug. This 
negative experience might suddenly turn quite 
positive under t he appropriate conditions. His-
tory is instructive here. Phenothiazines and 
demethylchlortetracyclines are potent phototoxic 
agents . It was only after widespread use that 
this side effect became known. The reason of 
course is t hat we don't readily see what is un-
expected. 
In any case, I would wager two dozen come-
dones that the thiurams have phototoxic capa-
bi Jj ties. 
Sincerely yours, 
Albert M. Kligman, M.D., Ph.D. 
